Chris Wood is out with an attention-getting ad for Casey’s Extraordinary Technology newsletter ($1,497 “on sale!”), and readers are asking their favorite neighborhood Gumshoe… so let’s get you some answers. The basic pitch is that there’s a kind of power that he calls “Bell Power,” and it’s growing like mad and could supply all our […]
It’s a tradition to give thanks at this time of the year, and one of the things we are supremely grateful for is the never-ceasing parade of promises that the financial newsletter industry throws our way in their perpetual search for new subscribers. After all, without those overhyped promises in their teaser ads we’d have […]
This week there’s been quite a bit of news in stocks that I follow fairly closely or own or have featured in the past as “Idea of the Month” candidates for the irregulars, so I do have a bit of a teaser campaign to talk to you about (that’s the Casey bit), but I’m going […]
“Odds are you never heard of this murderous disease that quickly kills more than 250,000 Americans every year. “If your doctor correctly diagnoses it within 24-36 hours of its onset you could live. “If he can’t… and most doctors can’t… your life is a coin toss. “HEADS YOU LIVE TAILS YOU DIE “But this company’s […]
Last week we started to look into the “Curing Cancer Portfolio” tease from the Casey Research folks, and, as promised, today we’re going to finish up and identify the other three picks for you. He says optimistically. (I’m writing as I research here, so we’ll have to see if all three disrobe for the Thinkolator […]
I haven’t written about a biotech teaser pick or about any of the Casey newsletters for quite a while, so this one that many readers sent in recently looked like a fine target for the Thinkolator today … The pitch is from Alex Daley, the “Chief Technology Investment Strategist” for Casey Research, and he’s trying […]
Monthly newsletter highlighting technology and biotech stocks.